Navigation Links
National Academy of Sciences Recognizes Monsanto's Chief Technology Officer for Development of Agricultural Biotechnology

ST. LOUIS, Jan. 24 /PRNewswire-FirstCall/ -- The National Academy of Sciences (NAS) Council announced this week that Robert T. Fraley, Ph.D., chief technology officer and executive vice president for Monsanto, has been awarded the NAS Award for the Industrial Application of Science. This prize is awarded every three years for original work of intrinsic scientific importance and with significant, beneficial applications in industry -- in this case, the improvement of crops through biotechnology.

The NAS council awarded Fraley for his development of "technologies which enabled the production of the world's first transgenic crops. These plants have increased productivity, reduced chemical use and profoundly changed global agriculture."

"On behalf of the Monsanto team, I congratulate Robb on this tremendous recognition," said Hugh Grant, chairman, president and chief executive officer of Monsanto.

"It was Robb's leadership that brought the first products developed through biotechnology to market in the 1990s," Grant said. "As a result of these efforts, literally millions of farmers around the world benefit from the use of these products including the ability to increase yield and profitability on farm while simultaneously reducing global agriculture's footprint on our environment."

Fraley's development of the first biotechnology product, which first launched on four million acres in 1996, paved the way for a renaissance in global agriculture. Today, seven million farmers in 18 countries grow biotech crops on more than 160 million acres. The 12 products resulting from his work represent one of the most successful new agricultural technologies ever launched.

The annual growth and acceptance of these products, steady addition of new products and a pipeline of future products emerging from this technology demonstrate the ongoing, sustainable nature of agricultural biotechnology as a key agronomic tool to enhance the production of the world's major food, feed and fiber crops.

Monsanto Company (NYSE: MON) is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information, please visit:

SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. For creating new field of science, Texas chemist wins international prize
2. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
3. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
4. Tasker Products to Showcase Tasker Blue at International Poultry Expo
5. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
6. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
7. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
8. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
9. Carbon offset warning from international team of scientists
10. Palomar and Q-MED AB Enter Into International Distribution Agreement
11. International Association of Fire Fighters (IAFF) Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO-Oximetry
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):